Search results for: Innovation Policy Prize

Opportunities for Utilising ‘Real World Data’ in South Korea

20 October 2017

…local government and public institutions, or research organisations with an academic or public policy purpose. Opportunities for data linkage are limited, and the patient consent models that guide data use…

Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? A Summary of a Symposium held at HTAi Rome 2017

31 October 2017

…an effective treatment; the innovation value of creating a new mode of action; the ability to preserve the safety of procedures that rely on the use of antibiotics (enablement value);…

OHE at ISPOR’s 20th Annual European Congress: Presentations

…Cancer’ special issue of the Journal of Cancer Policy. Is willingness to pay higher for cancer prevention and treatment? from Office of Health Economics   In another poster, Koonal examined…

Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure

18 December 2017

This report analyses patient access in the UK to new medicines authorised via the centralised procedure between 2011 and 2016. The centralised procedure was created in 1995 to facilitate access…

OHE’s In-house Publications Are Now Indexed by RePEc

8 May 2018

OHE is on RePEc: find publications from the Office of Health Economics in Research Papers in Economics. For many years, we’ve been publishing our work – free to read – on…

Should Drug Prices Differ by Indication? The Debate on Indication-based Pricing

11 May 2018

OHE Consulting has produced a report summarising the literature on indication-based pricing and how it has been applied in the U.S. and 5 European countries. OHE Consulting has produced a…

A Critique of Hill et al. (2018) on Estimated Costs of Production for the WHO Essential Medicines List

19 May 2018

OHE Consulting produces a report critiquing a paper by Hill et al. (2018) on estimated costs of production for the WHO Essential Medicines List. This OHE Consulting Report, published today,…

Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS

29 August 2018

OHE Consulting produces a report on Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS. This OHE Consulting Report, published today, reviews “Measurement of Medicines Expenditure in the…

Private Provision of Publicly Funded Health Care: The Economics of Ownership

10 September 2018

…reduce waiting times and drive innovation and efficiency improvements. Depending on the viewpoint, private ownership is either a disaster or a salvation for the NHS. A new OHE Briefing, by…